illumina inc (ILU:Frankfurt)
illumina inc (ILU) Snapshot
|
Open
€56.13
|
Previous Close
€57.82
|
|
|
Day High
€56.13
|
Day Low
€55.62
|
|
|
52 Week High
05/20/13 - €57.82
|
52 Week Low
06/22/12 - €30.43
|
|
|
Market Cap
--
|
Average Volume 10 Days
273.0
|
|
|
EPS TTM
--
|
Shares Outstanding
0.0
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
illumina inc (ILU) Related Businessweek News
illumina inc (ILU) Details
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company’s sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia’s; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
illumina inc (ILU) Top Compensated Officers
illumina inc (ILU) Key Developments
Illumina Inc. announced the full commercial availability of BaseSpace, the company's genomics cloud computing and storage platform. BaseSpace Apps is now out of beta status, and includes a full-fledged e-commerce system that allows customers to quickly and easily purchase Illumina and third-party bioinformatics applications (apps). BaseSpace e-commerce transactions are based on BaseSpace iCredits, a medium of exchange that can be purchased and spent within BaseSpace. BaseSpace has rapidly become a valuable platform for bioinformatics app developers. During the beta period, users launched individual BaseSpace apps more than 4,000 times. Now, with BaseSpace iCredits, developers can easily add e-commerce functionality to their apps, leveraging Illumina's complete payment solution. Through the BaseSpace ecosystem, a diverse collection of new apps are now available for Illumina's MiSeq and HiSeq systems. For example, Elsevier Publishing, the world's leading publisher of scientific and health information, has released a BaseSpace app that enables users to submit data directly into the peer-review publication process.
Illumina Inc. announced it is collaborating with leading providers of liquid handling robotic platforms to develop automation methods for its best-in-class TruSeq and Nextera Sample Preparation kits. Initial partners in this effort are Beckman Coulter Life Sciences, Eppendorf, Hamilton Robotics, PerkinElmer, and Tecan. These partnerships, and the resulting methods, reflect Illumina's commitment to creating the simplest, most efficient next-generation sequencing (NGS) workflows, and represent an important step towards enabling complete, end-to-end solutions for customers. Under the agreements, sample preparation kits sold by Illumina will be automated by the partners, who will develop, distribute and install the methods on customers' robots, as well as provide technical support. Illumina will assist during development, testing and promotion of the methods.
Illumina Inc. Presents at UBS Global Healthcare Conference, May-20-2013 11:30 AM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Marc A. Stapley, Chief Financial Officer and Senior Vice President.
| Recently Viewed | |||
| ILU:GR | €55.71 EUR | -2.11 | |
| Company | Last | Change |
| Actelion Ltd | SFr.58.70 CHF | -0.10 |
| Avago Technologies Ltd | $34.59 USD | +0.15 |
| BioMerieux | €74.70 EUR | +0.35 |
| QIAGEN NV | €14.47 EUR | +0.02 |
| Siemens Ltd | 598.90 INR | -1.05 |
| View Industry Companies | ||
Industry Analysis
ILU
Industry Average
| Valuation | ILU | Industry Range |
| Price/Earnings | 92.2x |
|
| Price/Sales | 7.4x |
|
| Price/Book | 6.8x |
|
| Price/Cash Flow | 74.5x |
|
| TEV/Sales | 5.8x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
To contact ILLUMINA INC, please visit www.illumina.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








